Participating supervisors on this PhD Programme

Rodrigos's image for web banner with WT (jpg)

WT4Y PhD Programme: Supervisors for 2016/17

Supervisor Research Field                      Location
Maria Alcolea Epithelial Stem Cell fate and plasticity; relevance for oesophageal cancer development SCI Gleeson Building
Roger Barker

Clinical aspects of Parkinson's and Huntington's disease including the study of cell based therapies to treat patients and iPS/iN work to study disease pathogenesis and novel therapeutics.

Brain Repair Centre

Paul Bertone Transcriptional regulation of pluripotency in ES cells and embryonic development SCI Gleeson Building
Serena Best Medical materials Cambridge Centre for Medical Materials
Allan Bradley Leading the Sanger Institute's Mouse Genomics Team, which uses the mouse as a model system to investigate the function of individual genes.  Wellcome Trust Sanger Institute
Simon Buczacki Colorectal cancers Cambridge Cancer Centre
Ruth Cameron Medical materials Cambridge Centre for Medical Materials
Peter Campbell Cancer genomics Wellcome Trust Sanger Institute
Kevin Chalut The physical biology of pluripotency and differentiation SCI Gleeson Building
Ana Cvejic Functional characterisation of novel genes implicated in human blood formation and pathologies using zebrafish as an in vivo model. Wellcome Trust Sanger Institute
Sara-Jane Dunn Biological Computation Microsoft Research
Jasmin Fisher Executable Biology Microsoft Research
Robin Franklin Factors regulating adult neural stem cell fate following CNS injury, with particular emphasis of oligodendrocyte differentiation Clifford Albutt Building
Michaela Frye Mechanism regulating stem cell self-renewal and differentiation processes in normal epithelial tissues and cancer SCI Gleeson Building
Cédric Ghevaert Production of platelet and red cells for tranfusion in humans from pluripotent stem cells using reprogramming techniques CIMR
Richard Gilbertson Childhood brain tumours Cambridge Cancer Centre
Bertie Göttgens The transcriptional control of normal and leukaemic blood stem/progenitor cells CIMR
Tony Green Regulation and differentiation in normal haematopoietic stem cells and in myelo-proliferation disorders CIMR
Myriam Hemberger How stem cell self-renewal and differentiation is controlled Babraham Institute
Brian Hendrich Transcriptional control  of stem cell fates SCI Gleeson Building
Daniel Hodson Mutation timing in lymphomagenesis Clifford Albutt Building
Meritxell Huch Adult tissue regeneration and its implications in disease and cancer Gurdon
Brian Huntly Characterisation of the molecular and celluar biology of cancer stem cells and to compare and contrast these to normal stem cells CIMR
Joo-Hyeon Lee  Stem cells and niches SCI Gleeson Building
Phil Jones We use in vivo lineage tracing in transgenic mouse models to define normal stem and progenitor cell behaviour in squamous epithelia and how this is changed by mutations and carcinogens in preneoplasia Wellcome Trust Sanger Institute
Ragnhildur Thóra Káradóttir Neuronal activity and neurotransmitter regualtion of central nervous systems stem/precursor cell fate SCI Gleeson Building
David Kent Single Cell Fate Choice in Normal and Malignant Stem Cells Clifford Albutt Building
Bon-Kyoung Koo Functional characterisation of E3 ubiquitin ligases in stem cell-niche interactions (Epithelial Tissues) SCI Gleeson Building
Elisa Laurenti Human haematopoietic stem cells in health and disease  Clifford Albutt Building 
Pentao Liu Stem cells in development and cancer, reprogramming and iPS cells Wellcome Trust Sanger Institute
Rick Livesey Human stem cell models of neurological disease Gurdon
Keith Martin Stem cells as a potential treatment for glaucoma Cambridge Neuroscience
Alfonso Martinez Arias The principles that govern cell fate transitions during development from the perspective of interactions between signaling and transcription factor networks Dept of Genetics
Andrew McCaskie Regenerative therapies for bone and cartilage repair Dept of Surgery, Addenbrookes Hospital
Simón Méndez-Ferrer Blood stem cell niches Cambridge Blood Centre, Dept. of Haematology
Florian Merkle Human stem cell-based models of obesity and neurodegeneration LRM
Jennifer Nichols Embryonic pluripotency and its relationship to stem cells SCI Gleeson Building
Anna Philpott Proliferation versus differentiation in stem and progenitor cells Hutchison/MRC Research Centre, Dept. of Oncology
Cristina Pina Haematopoietic stem cells CIMR
Stefano Pluchino Mechanisms of stem cell-immune cell interactions and manipulation of stem cell functions towards repair and regeneration of the injured nervous system Clifford Albutt Building
Wolf Reik The dynamics, mechanisms and biological purposes of genome-wide epigenetic reprogramming in germ cells and early embryos Babraham Institute
Ingo Ringshausen Haematopoeitic stem cells and malignancies Clifford Albutt Building
David Rowitch Glial cells and response to injury Clifford Albutt Building
Peter Rugg-Gunn Epigenetic mechanisms controlling pluripotency and differentiation in embryonic stem cells Babraham Institute
José Silva Biology of induced pluripotency SCI Gleeson Building
Ben Simons

Mechanisms of stem cell fate in maintenance, repair and regeneration of adult tissues, and pathways leading to ageing and disease. Regulation of progenitor cell fate in late stage development of tissues

Cavendish Laboratory
Sanjay Sinha

Vascular diseases

Dept. of Surgery, LRM
Austin Smith Embryonic stem cells: self-renewal, pluripotency, commitment, lineage restriction, reprogramming SCI Gleeson Building
Azim Surani Epigenetic regulation of cell fate determination from pluripotent stem cells Gurdon
Ludovic Vallier Mechanisms controlling differentiation in pluripotent stem cells into definitive endoderm Dept. of Surgery, LRM
George Vassiliou Leukaemic haemopoietic stem cells Wellcome Trust Sanger Institute
Christine Watson Stem and progenitor cell fate in mammary gland Dept of Pathology
Doug Winton Epithelial and cancer stem cells CR-UK, CRI
Matthias Zilbauer Intestinal stem cell biology Dept. of Paediatrics, Addenbrookes Hospital
Back to top

BRC - Brain Repair Centre

CIMR - Cambridge Institute for Medical Research

CR-UK, CRI - Cancer Research UK, Cambridge Research Institute

Gurdon - The Wellcome Trust/Cancer Research UK Gurdon Institute

LRM - Anne McLaren Laboratory for Regenerative Medicine

LMB - MRC Laboratory of Molecular Biology

PDN - Department of Physiology, Development and Neuroscience

Back to top

Web design by Studio 24 / Back to top